Histologic and molecular features shared between antibody‐mediated rejection of kidney allografts and chronic histiocytic intervillositis support common pathogenesis
The Journal of Pathology · 2025
DOI: 10.1002/path.6413 ↗At a glance
Journal article in The Journal of Pathology, 2025. Written by Léonie Albersammer and 18 co-authors. Institution: Department of Pathology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker, Paris, France. Major MEDLINE topics: Kidney Transplantation, Graft Rejection, Placenta Diseases, Chorionic Villi. Cited 6 times so far (Crossref); 59 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Contrat de Recherche Clinique, Fondation Université Paris Cité.
Abstract (original language)
Chronic histiocytic intervillositis (CHI) is an inflammatory condition of the placenta, characterised by an abnormal, mainly macrophagic infiltrate within the intervillous space. Recent research suggests that CHI results from a ‘maternal‐foetal rejection’ mechanism, because at least some CHI cases fulfil the criteria for antibody‐mediated rejection (AMR) of kidney allografts according to the Banff classification [i.e. presence of anti‐human leukocyte antigen (HLA) paternal antibodies activating the complement or foetal‐specific antibodies (FSA), a macrophage‐rich infiltrate, and positive C4d immunostaining]. To gain further insights into CHI pathogenesis, we aimed to refine the phenotype of the inflammatory infiltrate using a multiplex immunofluorescence technique and to compare the mRNA signatures between CHI and AMR of kidney allografts. Twelve patients with C4d+ FSA+ CHI were included in the study and compared to a control group of 5 patients without inflammatory lesions on placental examination. We developed a multiplex immunofluorescence panel to identify CD4+ and CD8+ T lymphocytes, CD68+/CD206− and CD68+/CD206+ macrophages, and NK cells in the villi and intervillous space. Molecular signatures were studied using NanoString® technology and the B‐HOT panel recommended by the Banff classification for kidney allografts. Multiplex immunofluorescence revealed that the infiltrate in the intervillous space was mainly composed of CD68+/CD206− macrophages as well as a higher proportion of CD8+ lymphocytes in patients with CHI compared to controls. Densities of NK cells and CD4 T cells were very low. Molecular signatures showed an overexpression of HLA class II genes, an IFN‐γ signature, and cytokine gene sets in C4d+ FSA+ CHI patients, also involved in kidney AMR. These results reinforce the paradigm of maternal‐foetal rejection. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Pathology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker, Paris, France.
- Department of Obstetrics and Gynecology, Hôpital Antoine Béclère, AP-HP, Université Paris Saclay, Clamart, France.
- Department of Kidney and Metabolic Diseases, Transplantation and Clinical Immunology, Necker Hospital, AP-HP, Paris, France.
- Unit of Embryo-Fetal Pathology, AP-HP, Antoine Béclère Hospital, Paris Saclay University, Clamart, France.
- Paris Translational Research Epidemiology and Biostatistics Department, Université de Paris, INSERM U970, PARCC, Paris, France.
- Necker-Enfants Malades Institute, Inserm U1151, Université de Paris, Paris, France.
ORCID profiles: Léonie Albersammer, Juliette Leon, Jelena Martinovic, Emilie Lebraud, Alexandre J Vivanti, Cristina Antal, Anne-Sophie Korganow, Nathalie Costedoat-Chalumeau, Alexandra Benachi, Julien Zuber, Marion Rabant
Funding
- Contrat de Recherche Clinique
- Fondation Université Paris Cité
Cite
APA
Albersammer, L., Leon, J., Martinovic, J., Dagobert, J., Lebraud, E., Bessières, B., Loeuillet, L., Eloudzeri, M., Vivanti, A. J., Dumery, G., Marchaudon, V., Antal, C., Korganow, A. S., Quibel, T., Costedoat-Chalumeau, N., Tsatsaris, V., Benachi, A., Zuber, J., & Rabant, M. (2025). Histologic and molecular features shared between antibody‐mediated rejection of kidney allografts and chronic histiocytic intervillositis support common pathogenesis. The Journal of Pathology. https://doi.org/10.1002/path.6413
Vancouver
Albersammer L, Leon J, Martinovic J, Dagobert J, Lebraud E, Bessières B, et al. Histologic and molecular features shared between antibody‐mediated rejection of kidney allografts and chronic histiocytic intervillositis support common pathogenesis. The Journal of Pathology. 2025. doi:10.1002/path.6413
BibTeX
@article{Albersammer2025,
author = {Albersammer, Léonie and Leon, Juliette and Martinovic, Jelena and Dagobert, Jessy and Lebraud, Emilie and Bessières, Bettina and Loeuillet, Laurence and Eloudzeri, Maëva and Vivanti, Alexandre J and Dumery, Grégoire and Marchaudon, Valérie and Antal, Cristina and Korganow, Anne-Sophie and Quibel, Thibaud and Costedoat-Chalumeau, Nathalie and Tsatsaris, Vassilis and Benachi, Alexandra and Zuber, Julien and Rabant, Marion},
title = {Histologic and molecular features shared between antibody‐mediated rejection of kidney allografts and chronic histiocytic intervillositis support common pathogenesis},
journal = {The Journal of Pathology},
year = {2025},
doi = {10.1002/path.6413}
}
EUVIMED